UA94213C2 - Use of monovalent antibody polypeptide that inhibits cd40 or cd40l activity in the manufacture of a medicament for treating or preventing autoimmune disease - Google Patents

Use of monovalent antibody polypeptide that inhibits cd40 or cd40l activity in the manufacture of a medicament for treating or preventing autoimmune disease

Info

Publication number
UA94213C2
UA94213C2 UAA200704215A UAA200704215A UA94213C2 UA 94213 C2 UA94213 C2 UA 94213C2 UA A200704215 A UAA200704215 A UA A200704215A UA A200704215 A UAA200704215 A UA A200704215A UA 94213 C2 UA94213 C2 UA 94213C2
Authority
UA
Ukraine
Prior art keywords
antibody polypeptide
inhibits
medicament
treating
manufacture
Prior art date
Application number
UAA200704215A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Стивен Грант
Хайгун Лю
Кевин Моулдер
Original Assignee
Домантис Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Домантис Лимитед filed Critical Домантис Лимитед
Publication of UA94213C2 publication Critical patent/UA94213C2/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to use of monovalent antibody polypeptide that inhibits CD40 or CD40L activity for the manufacture of a medicament for treating or preventing autoimmune disease symptoms. The invention further relates to a composition comprising the antibody polypeptide and a second antibody polypeptide which binds a ligand other than CD40L, as well to a sustained release pharmaceutical composition.
UAA200704215A 2004-09-17 2005-09-16 Use of monovalent antibody polypeptide that inhibits cd40 or cd40l activity in the manufacture of a medicament for treating or preventing autoimmune disease UA94213C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61081904P 2004-09-17 2004-09-17

Publications (1)

Publication Number Publication Date
UA94213C2 true UA94213C2 (en) 2011-04-26

Family

ID=38866634

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200704215A UA94213C2 (en) 2004-09-17 2005-09-16 Use of monovalent antibody polypeptide that inhibits cd40 or cd40l activity in the manufacture of a medicament for treating or preventing autoimmune disease

Country Status (3)

Country Link
CN (1) CN101061140B (en)
UA (1) UA94213C2 (en)
ZA (1) ZA200702427B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2700651T3 (en) * 2008-07-18 2019-09-30 Bristol-Myers Squibb Company Compositions monovalent for CD28 binding and methods of use
MX354243B (en) * 2011-04-21 2018-02-20 Bristol Myers Squibb Co Antibody polypeptides that antagonize cd40.
WO2013014208A2 (en) * 2011-07-27 2013-01-31 Glaxo Group Limited Antigen binding constructs
BR112014009069A2 (en) * 2011-10-13 2020-10-27 Bristol-Myers Squibb Company cd40l antagonizing antibody polypeptides
ITTO20130012A1 (en) * 2013-01-09 2014-07-10 Metheresis Translational Res S A NEW ANTICORPAL FRAGMENTS, RELATED COMPOSITIONS AND USES
BR112016011027A2 (en) * 2013-12-20 2017-12-05 Genentech Inc method of producing an antibody, antibodies, pharmaceutical composition, polynucleotide, vector, host cell, method of treating asthma and method of treating a disorder
EP3851452A1 (en) * 2014-01-06 2021-07-21 F. Hoffmann-La Roche AG Monovalent blood brain barrier shuttle modules
WO2015134988A1 (en) 2014-03-07 2015-09-11 Bristol-Myers Squibb Company Method of using antibody polypeptides that antagonize cd40 to treat ibd
WO2016106158A1 (en) * 2014-12-22 2016-06-30 Systimmune, Inc. Bispecific tetravalent antibodies and methods of making and using thereof
CN107709355B (en) * 2015-05-04 2021-09-14 阿珀吉尼科斯股份公司 Single-chain CD40 receptor agonist proteins
JP6657392B2 (en) 2015-10-02 2020-03-04 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト Bispecific anti-human CD20 / human transferrin receptor antibodies and methods of use
CN114149508B (en) * 2021-11-25 2023-04-28 苏州普乐康医药科技有限公司 Fusion protein combined with CD40L and application thereof

Also Published As

Publication number Publication date
CN101061140A (en) 2007-10-24
CN101061140B (en) 2015-07-01
ZA200702427B (en) 2008-12-31

Similar Documents

Publication Publication Date Title
UA94213C2 (en) Use of monovalent antibody polypeptide that inhibits cd40 or cd40l activity in the manufacture of a medicament for treating or preventing autoimmune disease
NZ617196A (en) Activin-actrii antagonists and uses for increasing red blood cell levels
MY154984A (en) Preventing autoimmune disease
UA94734C2 (en) THERAPEUTIC ANTIBODIY WHICH BINDS TO b-AMYLOID PEPTIDE
TW200510349A (en) Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
UA93201C2 (en) Antibody neutralizing human tgf beta 1
TNSN07304A1 (en) Combination of xolair with immunosuppressive agent
MX2011006685A (en) Membrane type-1 matrix metalloprotein inhibitors and uses thereof.
TW200630093A (en) Dose forms
MX338338B (en) Compositions and methods useful for treatment of respiratory illness.
NZ702801A (en) Treatment of sanfilippo syndrome type b
MX2009006345A (en) Compounds useful as protein kinase inhibitors.
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
UA86621C2 (en) Glucagon receptor antagonists, preparation and therapeutic uses
MX2009003039A (en) Use of an anti-cd151 antibody in the treatment of cancer.
TW200734334A (en) Treatment of substance abuse
UA93709C2 (en) 12-imidazolyl-1-dodecanol and use thereof in the preparation of pharmaceutical compositions
MX2011000255A (en) Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer.
MXPA05007379A (en) Method of treating nausea, vomiting, retching or any combination thereof.
WO2009125981A3 (en) Pharmaceutical formulation
ATE497392T1 (en) THERAPY WITH ANTI-CD4 ANTIBODIES AND RADIATION
WO2008049842A3 (en) Egfr kinase inhibitor combinations for the treatment of respiratory and gastrointestinal disorders
ATE533488T1 (en) METHODS AND FORMULATIONS FOR MODULATING LYN KINASE ACTIVITY AND TREATING ASSOCIATED DISEASES
UA96926C2 (en) Use of sdf-1 for the treatment and/or prevention of neurological diseases
WO2009047513A3 (en) Antagonists of kisspeptin and uses thereof